BMY into Q1 earnings: modest shorts, bullish options tilt, Street sees upside
Bristol-Myers Squibb heads into its April 30 Q1 earnings call with an unusual combination — short sellers are quietly rebuilding positions, options traders are leaning more optimistic than usual, and the Street holds a…